Effects of electroconvulsive shock and serotonin axon lesions on beta-adrenergic and serotonin-2 receptors in rat brain.
D000777:Anesthetics / Q000494:pharmacology; D000818:Animals; D001369:Axons / Q000187:drug effects*; D001921:Brain / Q000502:physiology*; D002540:Cerebral Cortex / Q000502:physiology; D000242:Cyclic AMP / Q000378:metabolism; D004082:Dihydroalprenolol / Q000378:metabolism; D004565:Electroconvulsive Therapy; D005625:Frontal Lobe / Q000473:pathology; D006624:Hippocampus / Q000473:pathology / Q000502:physiology; D007650:Ketanserin; D009638:Norepinephrine / Q000378:metabolism; D010880:Piperidines / Q000378:metabolism; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D011976:Receptors, Muscarinic / Q000502:physiology; D011985:Receptors, Serotonin / Q000502:physiology*; D012701:Serotonin / Q000378:metabolism; D013134:Spiperone / Q000378:metabolism; D013312:Stress, Physiological / Q000473:pathology; D013997:Time Factors; D014316:Tritium
D000777:Anesthetics; D010880:Piperidines; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D011976:Receptors, Muscarinic; D011985:Receptors, Serotonin; D014316:Tritium; D012701:Serotonin; D013134:Spiperone; D004082:Dihydroalprenolol; D007650:Ketanserin; D000242:Cyclic AMP; D009638:Norepinephrine